key: cord-0879273-gm64qav7
authors: Chinloy, Peter; Jiang, Cheng; John, Kose
title: Investment, Depreciation and Obsolescence of R&D
date: 2020-06-25
journal: nan
DOI: 10.1016/j.jfs.2020.100757
sha: 63ce1979c377f6a9e916a764ff384dc2f621219d
doc_id: 879273
cord_uid: gm64qav7

Abstract Time-varying depreciation rates are estimated for research and development of the United States aggregate economy and innovation-intensive industries. Mean annual R&D depreciation rates are 31.5% for software, 41% for pharmaceuticals, 42% for semiconductors, and 30.4% for aggregate economy during 1978-2014. R&D depreciation rates vary across industries. R&D investment demand has separate elasticities in time-varying depreciation, interest rate and price growth, allowing for different rates of technology shifts across industries. Software R&D investment has the same magnitude of elasticities to depreciation, interest rate and price, supporting a user cost to apply. For pharmaceuticals and semiconductors, depreciation leads to more R&D investment that implies the effect of scale. For aggregate economy, depreciation reduces R&D investment more than interest rate, indicating obsolescence. Forecasting of R&D investment is improved at both industry and aggregate level. Forecastable time-varying depreciation, interest rate and price growth predict R&D investment based on the estimated demand function. The in-sample forecast comparison for 2015-2019 confirms the superiority to the alternative methods. Out-of-sample forecasts of R&D investment are carried out through 2025, and R&D capital stocks are constructed across industries and aggregate U.S. economy.

Time-varying depreciation in intellectual property products, or research and development (R&D) has been applied by Hall (2005) and Li and Hall (2020) . A natural extension is to construct a user cost of R&D investment with variable depreciation, and to study the effect of time-varying depreciation on investment demand. With estimated R&D investment, backchecking the accuracy of in-sample forecast against actual observations and predicting future investment become possible.

In the theoretical model, the demand of R&D investment is affected by a time-varying depreciation rate along with the interest rate and price growth. R&D investment demand has separate elasticities in time-varying depreciation, interest rate and price appreciation, allowing for different rates of technology shifts across industries. When elasticities of depreciation, interest and price are equal in absolute value, R&D investment depends on a single factor as the user cost. When the elasticities are not equal, time-varying depreciation indicates technology shifts from obsolescence or scale.

Obsolescence increases the cost of depreciation, which reduces R&D investment. Scale decreases the cost of depreciation, resulting in more R&D investment. Such effect of scale especially applies to R&D investment in pharmaceuticals. The trials and tests for drug and vaccine research and development have positive externalities. A drug or vaccine failing to address one disease has potential use for another disease with comparable genetic makeup.

Coronavirus families including SARS, MERS, and Covid-19 are cases where pharmaceutical firms with previous R&D investment have low barriers and cost to enter the subsequent efforts to J o u r n a l P r e -p r o o f cure new disease, leading to more R&D investment. These findings are particularly timely and relevant, given the financial instability and unquiet times that encompass the world currently.

Stationary time-varying depreciation rate, interest rate, and price growth are forecastable. Their forecasts, along with their estimated relationship with R&D investment, enable the prediction of R&D investment. By reserving a portion of the sample, observed actual investment compared with in-sample forecast allow for the verification of model accuracy.

The application is to the aggregate economy of United States, and R&D-intensive industries, such as software, pharmaceuticals, and semiconductors over a time window between 1978 and 2025. The sample period used for estimation is 1978-2014. The period 2015-2019 is reserved for in-sample forecast accuracy confirmation. The out-of-sample predicting ranges from 2020 to 2025. This paper finds that time-varying depreciation rates vary across aggregate economy and industries. The mean time-varying depreciation rate of overall U.S. R&D is 30.4% yearly, and the annual depreciation rate of software R&D is 31.5%. Li and Hall (2020) find the depreciation rate in software ranges between 31% and 34% annually, and it is 37% in Warusawitharana (2015) . We also demonstrate that the mean time-varying depreciation rate of pharmaceutical R&D is 41% annually, and that of semiconductors is 42%. Warusawitharana (2015) finds 41% depreciation rate in pharmaceuticals and 34% semiconductors.

Unit root tests show stationarity in time-varying R&D depreciation, real interest rate, and real R&D price growth. The real R&D investment is nonstationary, but the growth rate of real R&D investment is stationary. These series enter the investment demand function, allowing for forecasting of R&D investment. The model of intertemporal investment projects that investment is decreasing in interest rate and increasing in price appreciation. This condition applies to R&D J o u r n a l P r e -p r o o f investment in all estimations, including aggregate economy, software, semiconductors, and pharmaceuticals.

In software, the depreciation elasticity of investment is not different from those for interest rate and price growth in absolute value, which supports a single factor as the user cost.

The elasticity of software R&D investment in the user cost is -0.2. For the aggregate economy, the elasticity of investment to depreciation is -1.4, exceeding those for interest rates and appreciation. Reduced investment from depreciation in excess of that from interest rate implies obsolescence.

For pharmaceuticals, the depreciation elasticity of R&D investment is 1.5, and it is 0.8 for semiconductors. An increase in depreciation in these industries raises R&D investment, implying scale. Scale decreases the cost of depreciation, resulting in more investment. The estimates provide possible explanations for otherwise puzzling results in R&D estimation found by previous studies. Hall (2005) finds negative depreciation rates for pharmaceuticals, computers, and electrical machinery. On the other end, Knott et al. (2003) report depreciation rates of up to 100% annually for pharmaceuticals. These phenomena are consistent with scale, reducing the cost of subsequent R&D investment.

Across the aggregate economy and industries, the driver of change in R&D investment is time-varying depreciation. The interest rate and price appreciation elasticities of R&D investment are usually bounded in absolute value by the 0.2 for the user cost. Given the relative size of the elasticities, R&D investment responds to time-varying depreciation as opposed to interest rate and price. The results reinforce incorporating a time-varying depreciation rate in R&D investment modeling.

Our estimation improves forecasting of R&D investment at both aggregate and industry level. Forecasting R&D investment using its historical data is challenging, because it is nonstationary and subject to unpredictable events. The past data of R&D investment does not provide credible information in forecasting. This paper suggests forecasting R&D investment using the time-varying depreciation rate and their estimated relationship in demand function. The in-sample forecast of 2015-2019 is compared with actual observed R&D investment for verification. The mean forecast error of software R&D investment of our method is 2.0%, as opposed to 7.3% with the best alternative. The mean forecast error of aggregate R&D investment is 1.4%, as opposed to 3.5% of best alternative. This suggests that the model incorporates timevarying depreciation and estimated demand function of investment has superiority in forecasting.

Out-of-sample predictions of R&D investment for 2020-2025 are carried out using time-varying depreciation, given the verified better performance. The R&D capital stock is derived using time-varying depreciation rates and fitted R&D investment, so is its forecast.

Section 2 describes the treatment of time-varying R&D depreciation and summarizes industry-specific estimates found by previous studies. Section 3 outlines the theoretical model for depreciation and investment. The data are described in Section 4. Section 5 reports the estimated relationship among R&D investment, time-varying depreciation, interest rate and price, as well as the forecast of R&D investment and R&D capital. A conclusion is in Section 6.

J o u r n a l P r e -p r o o f Table 1 shows depreciation rates applied in the United States at the aggregate level to tangible and non-tangible assets. An annual depreciation rate of 15% to 16.5% is for R&D, doubled for declining balances (Mead, 2007; Okubo et al., 2006; Sliker, 2007; Fixler, 2009). 1 R&D predicts returns at the firm and industry (Lev and Sougiannis, 1996; Lev et al., 2008) , facilitating technology transfer (Griffith, Redding and Van Reenen 2004) . Tax laws and accounting procedures incentivize the expensing of R&D, despite benefits lasting for longer than a year. In the United States, research and development is fully 100% expensed in the current year. Outside the United States, research is expensed by development including prototypes is capitalized and subject to a depreciation schedule. 2 Firms using accelerated depreciation rates carry out greater investments than those using lower straight-line forms (Jackson, Liu and Cecchini 2009). Table 2 summarizes R&D depreciation rates in various industries found by recent studies. Hall (2005) uses production function and market valuation approaches, and the estimated R&D depreciation rate in computers range from -5% to 25% annually. Mamuneas (2005, 2006) find that the R&D depreciation rate is 29% in electronics and 26% in machinery. Huang and Diewert (2011) use a production function with an allowance for monopolistic 1 The capital stock determines R&D's contribution to output and its growth (Griliches, 1979 (Griliches, , 1994 (Griliches, , 1998 Griliches et al., 1987) . A firm's domestic sales as a proportion of gross domestic product measures contributions to output (Domar, 1961; Hulten, 1978) . The derived capital stocks exclude household consumer durables which embed R&D (Sichel and von Hippel 2019) . Governments in developed countries construct capital stocks of R&D (Organization for Economic Cooperation and Development 2000, 2009) . For the United States, the Bureau of Economic Analysis in the National Income and Product Accounts, has recognized R&D with a capital stock since 2013. During 2012-2017, equipment was 46%, structures 23% and R&D 31% of annual U.S. fixed investment.

competition, and their estimated annual R&D depreciation rates range from 1% in chemicals to 27% in transportation.

Warusawitharana (2015) finds a 28% annual depreciation for computer R&D using a market valuation procedure. Li and Hall (2020) , based on Li (2012) use a depreciation rate that solves a net present value condition. Computer R&D depreciates at between 28% and 36% annually. Computer design has a depreciation rate between 25% and 49% per year. Estimation is conducted via generalized method of moments and nonlinear least squares.

A measure of R&D output is by patent quantity count and quality in citations. Using counts, depreciation rates in manufacturing are 11% to 19% annually (Pakes and Griliches 1984, Pakes 1986) or 25% in Pakes and Schankerman (1984) . R&D has low costs of reproduction and difficulty of excluding others from use if patents are not enforceable. Adjusted for citations, the R&D depreciation rate is 2% to 6% annually (Lanjouw and Schankerman, 2004) . Qualityadjusted patents outperform in explaining firm market values . The depreciation rate for patents held by U.S. firms is between 13% and 27% annually using forward and backward citations (Bessen, 2008; Bessen and Maskin, 2009 ). Knott (2017) finds that the top 10% of patents earn 80% of royalties. Using to-date and future values, the depreciation rate is 3.4% annually for Australian patents (de Rassenfosse and Jaffe, 2018). Annual depreciation estimates in manufacturing range between 2% and 17% by Hirschey and Weygandt (1985) , between 5% and 20% by Goel (1990) and 12% by Nadiri and Prucha (1996) . Across industries within manufacturing, the annual R&D depreciation rate is between 11% and 20% (Lev and Sougiannis, 1996) and 2% to 46% (Ballester et al., 2003) . Internationally, the annual R&D manufacturing depreciation rate is 24% in Canada and 25% in the United States Mamuneas, 2005, 2006) . J o u r n a l P r e -p r o o f Hall (2005) notes a shift of R&D from pharmaceutical firms to biotechnology in health care. A similar movement of R&D from hardware to software occurs in information technology.

The shift to software occurs as this industry has become decentralized and global (Branstetter et al., 2019) . Future earnings and R&D intensity increase with firm size (Ciftci and Cready, 2011) , affected by the proximity to investor clusters (Bell et al., 2020) . Industrial concentration of R&D leads to the emergence and focus of star firms. Some firms invest intensively, leading to accelerated sales growth and concentration (Autor et al., 2017 (Autor et al., , 2020 3 . Concentration increases when R&D investment is sensitive to tax policy and credits (Thompson, 2017).

The investment with time-varying depreciation structure is applicable to any long-term capital expenditure, including property, plant, and equipment, as well as intangible intellectual property products. The model involving a time-varying depreciation rate adjusted for obsolescence and scale is particularly relevant to R&D investment.

The price of investing in a unit of R&D is . R&D investment is ( ). The demand of investment is downward sloping in price with ′ < 0. The price has capital gain =.

Innovation that reduces the cost of R&D leads to price deflation with < 0.

The investment's intertemporal maximization has discount rate + . The interest rate is with a multiplier for equity costs, leverage, and taxes, so the cost of financing is .

When = 1 the interest rate is sufficient for the cost of capital. R&D depreciation is at rate , 3 The concentration of R&D and the rise of superstar firms is not universal. Star firms locate in specific industries (Crouzet and Eberly, 2018, 2019) . In consumer products R&D leads to productivity but in health care to increased margins, given patent protection. Superstar firms are not becoming larger or more productive (Gutiérrez and Philippon, 2019). While firms with over 500 employees carry out two-thirds of R&D, they are no more productive than the overall economy.

J o u r n a l P r e -p r o o f which varies over time and across industries. The technology shift by , so the cost of depreciation is . When the coefficients on interest rate and depreciation are equal, they have the same impact on R&D investment. In this case, demand depends on the user cost + − .

A common elasticity applies to the user cost. Depreciation has the same investment elasticity in absolute value as interest rate and price change. When depreciation is constant, depreciation has no impact on incremental investment, regardless of its rate. Without time variation, depreciation is part of the intercept, and the user cost is − .

Having a separate coefficient on time-varying depreciation allows for obsolescence or scale in technology shifts. A well-behaved elasticity of investment demand in interest rate is negative. When the elasticity of investment in depreciation is larger and more negative than that for interest rate, there is obsolescence. There is scale when the elasticity of investment in depreciation is smaller than that for interest rates. A smaller elasticity for scale includes where investment is increasing in depreciation. In the limit, scale reduces the cost of depreciation, leading to a rise in investment.

Scale implies that 100% annual depreciation as found in Knott et al. (2003) The investment generates a flow of services renting for . At the discount rate + and price the rental price satisfies

The undiscounted rental is ( + ) = ( + − ) . The asset price of the investment per unit of rental or when = 1 is

) depends on rates of depreciation , interest and price appreciation , the finance margin and technology . 4

In discrete time, the discount rate as yield of + is earned one period ahead. The current numerator in the price formula becomes unity, resulting in the price of investment as = 1 + −

. Inverting, investment depends on + − . With the sign change from the inversion, investment is decreasing in interest rate and variable depreciation, and increasing in capital gains. For logarithmic investment and to a first-order approximation

). In the current period the discount rate is removed from the numerator. Linearizing to first order, = 1 1+ using to summarize the variables with elasticity . Taking logarithms = − ln(1 + ) ≅ − , the estimating equation. When there is no depreciation and the cost of capital multiplier is one, =

− the dividend growth of Gordon (1959) . The logarithm of the denominator involves a first-order approximation to ln ( − ) as in Campbell and Shiller (1988) .

The elasticity of investment in time-varying depreciation is . The interest rate elasticity of investment is . The elasticity of investment to price appreciation or cost growth is .

The interest rate elasticity of investment is negative. When the elasticity of investment for time-varying depreciation exceeds that for interest rate in absolute value, there is obsolescence.

Depreciation reduces investment more than interest rate, for a basis point increase in each. Scale happens when the depreciation elasticity is less than interest rate elasticity. Sufficient scale allows the depreciation elasticity to change sign. Increased depreciation raises investment, notably in industries with scale and externalities including pharmaceuticals and semiconductors.

When depreciation rate is constant, depreciation's effect is part of the intercept , and depreciation has no impact on the incremental change in R&D investment.

The time-varying depreciation application is to the R&D investment in aggregate economy and R&D-intensive industries in the United States, such as software, pharmaceuticals, and semiconductors. The source is the U.S. Bureau of Economic Analysis.

Aggregate and software data are quarterly R&D investments in nominal terms, ranging from 1978 to 2019. Pharmaceutical and semiconductor series are annual nominal R&D investments over the same time window. Real R&D investments are obtained by deflating the nominal series by R&D price appreciation. The real interest rate is the yield to maturity on the 3-month Treasury bill net of inflation. Real price appreciation in R&D is the growth rate of the relevant industry or aggregate R&D price index less inflation.

Expected time-varying depreciation is calculated as the difference between the expected investment-capital ratio and the expected capital stock growth rate. The best-fitting process of J o u r n a l P r e -p r o o f each derives the depreciation rate. The procedure is analogous to that in Warusaritharana (2015).

Therefore, a rate of obsolescence is a premium. Here, the coefficient of depreciation is a premium for obsolescence or a discount for scale. In each case, the cost of depreciation is the product of a rate and a technology shift. The process allows for sufficient scale and a negative impact of depreciation (Hall 2005 ) even as the rates are positive. The depreciation rate, along with the remaining variables, are subject to time-series testing for stationarity and forecasting.

Apart from consistency and extension of procedures, back-check is allowed from the in-sample forecasting performance.

Summary statistics of time-varying depreciation rate are listed in Table 3 . For the aggregate economy, the sample mean is 12.4% on a quarterly basis. Dividing 12.4% by the declining-balance factor 1.65 of Table 1 , the quarterly mean depreciation rate is 7.51%, annualized to be 30.4%. Using a comparable procedure for software, the annual mean depreciation rate is 31.5%. The mean depreciation rate is 41% for pharmaceuticals R&D and 42% for semiconductors R&D, both of which are on an annual basis. Figure 1 depicts timevarying R&D depreciation rates for the aggregate economy and software industry based on quarterly data, and for pharmaceuticals and semiconductors with annual data.

The time-series properties of the real interest rate, depreciation, real price appreciation, and real R&D investment determine their specification of the demand function. Column 1 has the flexible form, with separate investment elasticities in interest rate, depreciation, and price appreciation. The elasticity of R&D investment for time-varying depreciation rate is -1.375. The real interest rate elasticity is -0.166, whose absolute value is significantly lower than unity. Price appreciation has an elasticity of 0.176, significantly less than one. The aggregate R&D investment is elastic in depreciation, but relatively inelastic in interest rates and price appreciation. At the aggregate level, depreciation reduces R&D investment more than interest rate, suggesting obsolescence. The F-tests show that the depreciation elasticity is different from the elasticities for other two variables, supporting obsolescence given the sign.

Column 4 shows the case when the depreciation rate is constant and its effect on R&D investment is in the intercept. Aggregate R&D investment depends only on the real interest rate and real price growth. Compared to results in column 1, the R&D interest elasticity falls to -0.001 and that of price growth is reduced to 0.152. With constant depreciation, R&D investment responds minimally to interest rates and prices, and obsolescence is eliminated. The driver of aggregate R&D investment is time-varying depreciation.

In Table 7 , panel A reports the estimates of R&D investment for pharmaceuticals with annual data. In columns 1-3, pharmaceutical R&D investment is not sensitive to real interest rates or price appreciation, but the elasticity of R&D investment to time-varying depreciation is significant, ranging between 1.46 and 1.51. A higher depreciation rate leads to more R&D investment, implying scale. Panel B of Table 7 shows results for R&D investment for semiconductors with annual data. In columns 5-7, semiconductor R&D investment increases significantly with the incentivizing semiconductor firms to take on R&D investments. Scale potentially explains findings of negative depreciation rates in industries related to semiconductors. Hall (2005) finds rates of R&D depreciation ranging between -5% to 25% in computers, -3% to 36% in electricals and -2% to 32% in machinery. The negative depreciation rates are not necessarily perverse.

Our estimation improves forecasting of R&D investment. R&D investment is nonstationary and subject to unpredictable events. The past data of R&D investment does not provide credible information in forecasting. The time-varying depreciation rate, interest rate, and price growth are stationary and forecastable based on their best-fitted time-series models. The forecasts of these variables and their estimated relationship with R&D investment allow for within-sample verification and out-of-sample prediction for R&D investment. The capital stock of R&D is a weighted sum over depreciation and R&D investment. The investment structure is applicable to any type of depreciable asset. High technology has been confirmed as being a rapidly depreciating asset. Motor vehicles and equipment are candidates for testing time-varying depreciation too. The application is also appropriate to more slowly depreciating assets including commercial and residential structures. Hulten and Wykoff (1981a, 1981b) . Table 2 reports the R&D depreciation rates in a variety of industries found in the rencent literature, including Hall (2005) , Mamuneas (2005, 2006) , Huang and Diewert (2011), Warusawitharana (2015) , Li and Hall (2020) Table 3 reports the summary statistics of time-varying depreciation rate for the aggregate R&D investment in the U.S., and the sectoral R&D investment in software, pharmaceutical and semiconductor industries. Due to the frequency of available data, depreciation rate is calculated quarterly for aggregate and software R&D, and yearly for pharmaceutical and semiconductor R&D. + . The null hypothesis is that ≥ 0 and the variable is nonstationary. The alternative hypothesis is that < 0 and the variable is stationary. The lag order of the augmented part is selected based on Akaike information criterion. The t-statistic of are in the parenthesis, *** indicates significance at 1% level, ** indicates significance at 5% level, and * indicates significance at 10% level. Variables for aggregate and software R&D investment are in the quarterly frequency. Variables for pharmaceutical and semiconductor R&D investment are in the yearly frequency. Conclusion: the time-varying depreciation rates, real interest rate and R&D price growth are stationary in levels. R&D investments are stationary in first differences. Table 6 reports the regression results of aggregate R&D investment in for the U.S. quarterly over 1978-2014. Dependent is the real R&D investment growth. Independent variables are combinations of the real interest rate, the time-varying aggregate R&D depreciation rate and the real R&D price growth. The signs are reversed to be consistent with the theoretical model. T-statistics are listed in the parenthesis. *** indicates the significance at 1%, ** indicates the significance at 5%, and * indicates the significance at 1%.

In columns 1-4, the elasticity of R&D investment to interest rate ranges between nearly zero and -0.17. In R&D price appreciation, the elasticity of investment is between 0.15 and 0.19. The depreciation elasticity is ranges from -0.10 to -1.4. R&D investment is elastic in depreciation, but relatively inelastic in interest rates and price appreciation. Depreciation reduces R&D investment more than interest rate, indicating obsolescence. Columns 5-6 impose the user cost. The elasticity of aggregate R&D investment to the user cost is -0.14. Imposing a user cost leads to an inelastic demand that suppresses the depreciation response.

The lower table shows the F-test results of the equality of parameters of regression 1. The results indicate the absolute value of regression parameter of depreciation is different from the other two variables, supporting obsolescence given its sign. Table 7 reports the regression results of R&D investment for pharmaceutical industry and semiconductor industry annually over 1978-2018. Dependent is the real R&D investment growth in pharmaceutical industry and semiconductor industry, respectively. Independent variables are combinations of the real interest rate, the time-varying aggregate R&D depreciation rate and the real R&D price growth. The signs are reversed to be consistent with the theoretical model. T-statistics are listed in the parenthesis. *** indicates the significance at 1%, ** indicates the significance at 5%, and * indicates the significance at 1%.

In columns 1-4, pharmaceutical R&D investment is increasing in depreciation rate, with an elasticity of between 1.46 and 1.51. It is not sensitive to interest rates or price appreciation. Time-varying depreciation leads to more R&D investment in pharmaceutical industry, suggesting scale.

In columns 5-8, semiconductor R&D investment is increasing in depreciation rate, with an elasticity of between 0.82 and 0.86. It is not sensitive to interest rates or price appreciation. Time-varying depreciation leads to more R&D investment in semiconductor industry, suggesting scale. Table 8 shows the maximum likelihood estimation results for all the parameters of ARIMA models. The t-statistics are listed in the parentheses. *** indicates significance at 1% level, ** indicates significance at 5% level, and * indicates significance at 10% level. Table 9 shows the in-sample forecast error comparison for software R&D investment (Panel A) and aggregate R&D investment (Panel B) quarterly from 2015 to 2019. Our forecast is based on the forecasts of time-varying depreciation rate, interest rate, price growth and their estimated relationship with R&D investment. The ETS model forecasts the future values of R&D investment based on its historical data via an exponential smoothing state space model (see Hyndman et al., 2002, and Hyndman et al., 2008) . Figure 4 presents the quarterly software R&D capital stock and aggregate R&D capital stock from 1981 to 2025 derived from three methods. The black curve represents the R&D capital stock from Method 1 with constant depreciation rate and actual R&D investment. The red curve represents R&D capital stock from Method 2 with time-varying depreciation rate and actual R&D investment. The blue curve represents R&D capital stock from Method 3 with time-varying depreciation rate and estimated R&D investment based on the demand function, which also enables the forecasting of R&D capital stock.

Concentrating on the fall of the labor share

The fall of the labor share and the rise of superstar firms

The economic value of the R&D intangible asset

Do tax cuts produce more Einsteins? The impacts of financial incentives vs. exposure to innovation on the supply of inventors

Depreciation estimation, R&D capital Stock, and north American manufacturing productivity growth

R&D depreciation, stocks, user costs and productivity growth for US knowledge intensive industries

The value of U.S. patents by owner and patent characteristics

Sequential innovation, patents, and limitation

The IT revolution and the globalization of R&D

The dividend-price ratio and expectations of future dividends and discount factors

Scale effects of reflected in earnings and returns

Intangibles, investment, and efficiency

Econometric evidence on the depreciation of innovations

Forecasting time series with complex seasonal patterns using exponential smoothing

Likelihood ratio statistics for autoregressive time series with a unit root

On the measurement of technological change

Accounting for Research and Development Costs

Accounting for R&D in the national accounts

The substitutability of labor, capital and R&D in US manufacturing

Dividends, earnings and stock prices

Mapping the two faces of R&D: productivity growth in a panel of OECD industries

Issues in assessing the contribution of research and development to productivity growth

Productivity, R&D, and the data constraint

R&D and productivity: the econometric evidence

The value of patents as indicators of inventive activity

Annales d'Economie et de Statistique 79-80, special issue in memory of Zvi Griliches

Market value and patent citations

Amortization policy for advertising and research and development expenditures

Estimation of R&D depreciation rates: a suggested methodology and preliminary application

Growth accounting with intermediate inputs

The measurement of economic depreciation using vintage asset prices

Depreciation, Inflation and the Taxation of Income from Capital

A state space framework for automatic forecasting using exponential smoothing methods

The admissible parameter space for exponential smoothing models

On the informational usefulness of R&D capitalization

Depreciation of Business R&D Capital

Depreciation of business R&D capital

R&D depreciation rates in the 2007 R&D satellite account

Cramming more components onto integrated circuits

Understanding Moore's Law: Four Decades of Innovation

Estimation of the depreciation rate of physical and R&D capital in the U.S. total manufacturing sector

BEA's research and development satellite account

Organization for Economic Cooperation and Development

Organization for Economic Cooperation and Development

Estimating distributed lags in short panels with an application to the specification of depreciation patterns and capital stock constructs

The rate of obsolescence of patents, research gestation lags, and the private rate of return to research resources

Patents as options: some estimates of the value of holding European patent stocks

Household innovation, R&D, and new measures of intangible capital